Chronic Glucocorticoid Exposure Potentiates Placental Chorionic Plate Artery Constriction: Implications for Aberrant Fetoplacental Vascular Resistance in Fetal Growth Restriction
The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
Fetal growth restriction (FGR) is a serious pregnancy complication, resulting in significant perinatal morbidity and mortality. Increased vascular resistance in the fetoplacental circulation is a hallmark of FGR and is associated with enhanced vasoconstriction of the resistance arteries in the placenta, the chorionic plate arteries (CPAs). Although the cause is unknown, FGR is associated with excess exposure to glucocorticoids (GCs), key mediators of vascular resistance in the systemic circulation. We hypothesized that GCs alter CPA reactivity, thereby contributing to the altered blood flow dynamics seen in FGR. We aimed to examine the acute and chronic effects of GCs on CPA reactivity and the operational mechanisms. Glucocorticoid receptors were highly expressed by CPA. 11β-Hydroxysteroid isoenzyme type 2 was detected within the endothelium, whereas 11β-hydroxysteroid isoenzyme type 1 was absent. Acute GC treatment significantly attenuated U46619-induced constriction. This effect was reversed by cotreatment with mifepristone or an endothelial NOS inhibitor. In contrast, chronic GC treatment potentiated U46619 constriction in a dose-dependent manner, which was partially abolished by mifepristone cotreatment. Similar effects were observed using a novel nonsteroidal glucocorticoid receptor-specific agonist. Chronic treatment with GCs altered the expression of several vasoactive factors, including thromboxane and bradykinin receptors, prokineticin-1, cyclooxygenase-2, and endothelial NOS. In summary, acute and chronic GC treatment exerts contrasting effects on CPA vasoreactivity. These opposing effects are consistent with temporal actions in other vascular beds and reflect activation of distinct nongenomic and genomic pathways. Chronic exposure to elevated GCs may contribute to the raised vascular resistance observed in the fetoplacental circulation in FGR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Human placental chorionic plate arteries abundantly express GC receptors; chronic GC exposure in vitro alters vasoreactivity, increasing vascular resistance and potentially contributing to hypertension (121).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [121]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basic and Clinical Pharmacology
Wingard, L. B. (1983) · Anesthesia & Analgesia · doi:10.1213/00000539-198308000-00015 · Cited by 630
Hafezi-Moghadam, A., Simoncini, T., Yang, Z., Limbourg, F. P., Plumier, J.-C., Rebsamen, M. C., Hsieh, C.-M., Chui, D.-S., Thomas, K. L., Prorock, A. J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-473 · Cited by 594
Fetal umbilical artery flow velocity waveforms and placental resistance: clinical significance
TRUDINGER, B. J., GILES, W. B., COOK, C. M., BOMBARDIERI, J., & COLLINS, L. (1985) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1985.tb01044.x · Cited by 561 · cited 1×
“In pregnancies complicated by FGR, Doppler waveform analyses of umbilical arteries identify an increase in resistance to blood flow in the fetoplacental circulation (5-7), indicating abnormal delivery of oxygen and nutrients to the fetus.”
BackgroundPlacental 11β‐hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure
Benediktsson, R., Calder, A. A., Edwards, C. R. W., & Seckl, J. R. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1230939.x · Cited by 536
Glucocorticoids and Vascular Reactivity
Yang, S., & Zhang, L. (2004) · Current Vascular Pharmacology · doi:10.2174/1570161043476483 · Cited by 308 · cited 1×
“Glucocorticoids (GCs) have well-documented actions in the regulation of systemic vascular reactivity, both via genomic and nongenomic pathways (11).”
BackgroundWallerath, T., Witte, K., Schäfer, S. C., Schwarz, P. M., Prellwitz, W., Wohlfart, P., Kleinert, H., Lehr, H.-A., Lemmer, B., & Förstermann, U. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13357 · Cited by 289 · cited 2×
“GCs are thought to modulate vascular tone through actions in both cell types: GCs inhibit vasodilator release (NO, prostacyclin) (34, 35) from endothelial cells and increase vasoconstrictive effects of catecholamines and angiotensin II by up-regulating 1B-adrenergic and AGTR1, respectively, in vascular smooth muscle c…”
BackgroundShams, M., Kilby, M. D., Somerset, D. A., Howie, A. J., Gupta, A., Wood, P. J., Afnan, M., & Stewart, P. M. (1998) · Human Reproduction · doi:10.1093/humrep/13.4.799 · Cited by 276
Li, M., Bullock, C. M., Knauer, D. J., Ehlert, F. J., & Zhou, Q. Y. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.4.692 · Cited by 269 · cited 1×
“Moreover, PROK1, a potent stimulator of smooth muscle constriction (38), is also enhanced, whereas AGRT1 was unaffected.”
BackgroundDevelopmental Origins of Adult Disease
Langley-Evans, S. C., & McMullen, S. (2010) · Medical Principles and Practice · doi:10.1159/000273066 · Cited by 263
Fetal Programming and Metabolic Syndrome
Rinaudo, P., & Wang, E. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153245 · Cited by 250
Pathology and clinical implications of abnormal umbilical artery Doppler waveforms
Kingdom, J. C. P., Burrell, S. J., & Kaufmann, P. (1997) · Ultrasound in Obstetrics & Gynecology · doi:10.1046/j.1469-0705.1997.09040271.x · Cited by 243 · cited 1×
“In pregnancies complicated by FGR, Doppler waveform analyses of umbilical arteries identify an increase in resistance to blood flow in the fetoplacental circulation (5-7), indicating abnormal delivery of oxygen and nutrients to the fetus.”
BackgroundUmbilical artery blood flow characteristics in normal and growth‐retarded fetuses.
EKSKINE, R. L. A., & RITCHIE, J. W. K. (1985) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1985.tb01399.x · Cited by 209
Sakaue, M., & Hoffman, B. B. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115315 · Cited by 181
Control of vascular resistance in the maternal and feto-placental arterial beds
Poston, L., McCarthy, A. L., & Ritter, J. M. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)00064-a · Cited by 166 · cited 2×
“A reduction of this magnitude would be expected to significantly affect spatial blood flow within the placenta due to the key role of CPA as placental resistance arteries (8).”
BackgroundSun, K., Yang, K., & Challis, J. R. G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3681 · Cited by 163
Role of gap junctions in the responses to EDHF in rat and guinea‐pig small arteries
Edwards, G., Félétou, M., Gardener, M. J., Thollon, C., Vanhoutte, P. M., & Weston, A. H. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703009 · Cited by 144 · cited 1×
“Interestingly, carbenoxolone appeared to abolish the hydrocortisone-induced increase in U46619 vasoconstriction; this is likely to be an 11 -HSD2-independent effect of carbenoxolone on vascular function, as a gap junction inhibitor (49, 50), or by increasing apoptosis (20).”
BackgroundCharacterization and chromosomal mapping of the human thromboxane A2 receptor gene.
Nüsing, R. M., Hirata, M., Kakizuka, A., Eki, T., Ozawa, K., & Narumiya, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74595-5 · Cited by 138 · cited 1×
“TBX-R up-regulation is particularly pertinent to the current study because GCs potentiated constriction in response to U46619, a thromboxane-mimetic, and the TBX-R contains a GRE in its promoter region (39).”
BackgroundSchulz, M., Eggert, M., Baniahmad, A., Dostert, A., Heinzel, T., & Renkawitz, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203268200 · Cited by 135 · cited 1×
“Although this was not statistically significant, it may reflect a GR agonist effect, as previously described in cells with high receptor density (30, 31).”
BackgroundMaternal, but not fetal, administration of corticosteroids restricts fetal growth
Newnham, J. P., Evans, S. F., Godfrey, M., Huang, W., Ikegami, M., & Jobe, A. (1999) · The Journal of Maternal-Fetal Medicine · doi:10.1002/(sici)1520-6661(199905/06)8:3<81::aid-mfm3>3.0.co;2-n · Cited by 134 · cited 1×
“It has been speculated that the ensuing elevated exposure of the fetoplacental unit to cortisol contributes to the pathogenesis of FGR, a hypothesis supported by reduced birth weight in animal models after maternal GC administration (17-19) or gene ablation of 11 -HSD2 (20).”
BackgroundEffect of antenatal betamethasone administration on placental vascular resistance
Wallace, E. M., & Baker, L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08229-4 · Cited by 127 · cited 1×
“pregnancies complicated by severe FGR (27, 28).”
Ain, R., Canham, L. N., & Soares, M. J. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06039 · Cited by 123 · cited 1×
“It has been speculated that the ensuing elevated exposure of the fetoplacental unit to cortisol contributes to the pathogenesis of FGR, a hypothesis supported by reduced birth weight in animal models after maternal GC administration (17-19) or gene ablation of 11 -HSD2 (20).”
BackgroundApoptosis in Rat Placenta Is Zone-Dependent and Stimulated by Glucocorticoids1
Waddell, B. J., Hisheh, S., Dharmarajan, A. M., & Burton, P. J. (2000) · Biology of Reproduction · doi:10.1095/biolreprod63.6.1913 · Cited by 114 · cited 2×
“Interestingly, carbenoxolone appeared to abolish the hydrocortisone-induced increase in U46619 vasoconstriction; this is likely to be an 11 -HSD2-independent effect of carbenoxolone on vascular function, as a gap junction inhibitor (49, 50), or by increasing apoptosis (20).”
BackgroundInhibition of Prostaglandin Synthesis by Glucocorticoids in Human Endothelial Cells*
Phillips, G. D. L., Campbell, W. B., & Johnson, A. R. (1986) · Endocrinology · doi:10.1210/endo-119-1-62 · Cited by 97 · cited 1×
“GCs are thought to modulate vascular tone through actions in both cell types: GCs inhibit vasodilator release (NO, prostacyclin) (34, 35) from endothelial cells and increase vasoconstrictive effects of catecholamines and angiotensin II by up-regulating 1B-adrenergic and AGTR1, respectively, in vascular smooth muscle c…”
BackgroundInhibitory effect of glucocorticoid on coronary artery endothelial function
Rogers, K. M., Bonar, C. A., Estrella, J. L., & Yang, S. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00364.2002 · Cited by 92 · cited 1×
“Previous studies have shown that NO bioavailability and eNOS expression is reduced by GC exposure (35, 41).”
BackgroundInoue, H., Umesono, K., Nishimori, T., Hirata, Y., & Tanabe, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9939 · Cited by 91 · cited 1×
“Glucocorticoid receptors (GRs) are expressed in both smooth muscle and endothelial cells (12, 13) together with both 11 -hydroxysteroid (11 -HSD) isoforms, indicating a possible role for prereceptor GC metabolism (14).”
BackgroundZhang, S., Jonklaas, J., & Danielsen, M. (2007) · Steroids · doi:10.1016/j.steroids.2007.03.012 · Cited by 88
Localization of 2 11β-OH Steroid Dehydrogenase Isoforms in Aortic Endothelial Cells
Brem, A. S., Bina, R. B., King, T. C., & Morris, D. J. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.459 · Cited by 86
Christy, C., Hadoke, P. W. F., Paterson, J. M., Mullins, J. J., Seckl, J. R., & Walker, B. R. (2003) · Hypertension · doi:10.1161/01.hyp.0000088855.06598.5b · Cited by 86
Functional characteristics of small placental arteries
McCarthy, A. L., Woolfson, R. G., Evans, B., Davies, D. R., Raju, S., & Poston, L. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70311-6 · Cited by 81 · cited 1×
“Previous myography studies have focused on short-term actions of a variety of pharmacological agents (9, 29).”
BackgroundCharacterization of Small Arteries Isolated From the Human Placental Chorionic Plate
Wareing, M., Crocker, I. P., Warren, A. Y., Taggart, M. J., & Baker, P. N. (2002) · Placenta · doi:10.1053/plac.2002.0825 · Cited by 78 · cited 2×
“Previous myography studies have focused on short-term actions of a variety of pharmacological agents (9, 29).”
BackgroundSelf-citationKenny, L. C., Baker, P. N., Kendall, D. A., Randall, M. D., & Dunn, W. R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704817 · Cited by 72 · cited 1×
“Interestingly, carbenoxolone appeared to abolish the hydrocortisone-induced increase in U46619 vasoconstriction; this is likely to be an 11 -HSD2-independent effect of carbenoxolone on vascular function, as a gap junction inhibitor (49, 50), or by increasing apoptosis (20).”
BackgroundSelf-citationMaternal betamethasone administration reduces binucleate cell number and placental lactogen in sheep
Braun, T., Li, S., Moss, T. J. M., Newnham, J. P., Challis, J. R. G., Gluckman, P. D., & Sloboda, D. M. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0123 · Cited by 66 · cited 1×
“It has been speculated that the ensuing elevated exposure of the fetoplacental unit to cortisol contributes to the pathogenesis of FGR, a hypothesis supported by reduced birth weight in animal models after maternal GC administration (17-19) or gene ablation of 11 -HSD2 (20).”
BackgroundSun, K., Adamson, S. L., Yang, K., & Challis, J. R. G. (1999) · Placenta · doi:10.1053/plac.1998.0352 · Cited by 64
Potentiation of angiotensin II action by corticosteroids in vascular tissue
Ullian, M. E., Walsh, L. G., & Morinelli, T. A. (1996) · Cardiovascular Research · doi:10.1016/0008-6363(96)00053-3 · Cited by 62 · cited 1×
“GCs are thought to modulate vascular tone through actions in both cell types: GCs inhibit vasodilator release (NO, prostacyclin) (34, 35) from endothelial cells and increase vasoconstrictive effects of catecholamines and angiotensin II by up-regulating 1B-adrenergic and AGTR1, respectively, in vascular smooth muscle c…”
BackgroundRocca, B., Loeb, A. L., Strauss, J. F., Vezza, R., Habib, A., Li, H., & FitzGerald, G. A. (2000) · Nature Medicine · doi:10.1038/72334 · Cited by 59 · cited 1×
“Thromboxane A2 has been implicated in the pathogenesis of FGR because transgenic mice overexpressing TBX-R deliver growth-restricted pups (40).”
BackgroundThromboxane and Prostacyclin Production by Different Compartments of the Human Placental Villus*
NELSON, D. M., & Walsh, S. W. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-3-676 · Cited by 59
Stillbirth and Fetal Growth Restriction
Bukowski, R. K. (2010) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e3181eba0db · Cited by 59
Edwards, A., Baker, L. S., & Wallace, E. M. (2002) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.2002.00782.x · Cited by 51 · cited 1×
“pregnancies complicated by severe FGR (27, 28).”
Expression and Regulation of Glucocorticoid Receptor in Human Placental Villous Fibroblasts
Lee, M.-J., Wang, Z., Yee, H., Ma, Y., Swenson, N., Yang, L., Kadner, S. S., Baergen, R. N., Logan, S. K., Garabedian, M. J., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0235 · Cited by 49 · cited 1×
“Villous placenta was included as a positive control (24) and showed strong nuclear immunoreactivity in the stromal compartment; no staining was detected in the negative control (Figure 1F and inset).”
BackgroundProperties of a progesterone-induced relaxation in human placental arteries and veins.
Omar, H. A., Ramirez, R., & Gibson, M. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.2.7852492 · Cited by 49
Short-Term Effects of Glucocorticoids in the Human Fetal-Placental Circulation in Vitro
Clifton, V. L., Wallace, E. M., & Smith, R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8541 · Cited by 43 · cited 2×
“However, in contrast to previous observations using the intact placental lobule perfusion technique (21), dexamethasone did not induce dilatation in unstimulated or preconstricted CPAs.”
BackgroundResultAldosterone and Dexamethasone Binding in Human Arterial Smooth Muscle Cells
Scott, B. A., Lawrence, B., Nguyen, H. H., & Meyer, W. J. (1987) · Journal of Hypertension · doi:10.1097/00004872-198712000-00018 · Cited by 41 · cited 1×
“Glucocorticoid receptors (GRs) are expressed in both smooth muscle and endothelial cells (12, 13) together with both 11 -hydroxysteroid (11 -HSD) isoforms, indicating a possible role for prereceptor GC metabolism (14).”
BackgroundWareing, M., Greenwood, S. L., & Baker, P. N. (2005) · Placenta · doi:10.1016/j.placenta.2004.11.008 · Cited by 40 · cited 1×
“This effect can also be reproduced by hypoxia (42).”
BackgroundSelf-citationMills, T. A., Wareing, M., Bugg, G. J., Greenwood, S. L., & Baker, P. N. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01577.x · Cited by 39 · cited 4×
“CPA reactivity has previously been shown to be altered in placentas from pregnancies complicated by FGR (10), with increased constriction to the thromboxane-mimetic, U46619, and increased relaxation to the nitric oxide (NO) donor, sodium nitroprusside (SNP), suggesting aberrant control of vascular tone contributes tow…”
BackgroundMethodResultInfluentialSelf-citationTower, C. L., Lui, S., Charlesworth, N. R., Smith, S. D., Aplin, J., & Jones, R. L. (2010) · Reproduction · doi:10.1530/rep-10-0307 · Cited by 34 · cited 1×
“Immunohistochemical staining for vascular markers -smooth muscle actin [ -SMA; vascular smooth muscle cells (VSMCs)] and CD31 (endothelial cells) was performed on 5- m tissue sections to identify CPA as previously described (23) using monoclonal antibodies: anti-CD31 and anti- SMA (Dako, Glostrup, Denmark) applied at…”
MethodSelf-citationPotter, S., Dennedy, M. C., & Morrison, J. J. (2002) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2002.01540.x · Cited by 30 · cited 1×
“Hydrocortisone, dexamethasone, and betamethasone also had an acute vasodilatory effect on rings of human umbilical arteries, preconstricted with 5-hydroxytryptamine (22).”
BackgroundWang, X., Athayde, N., & Trudinger, B. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2003.09.021 · Cited by 22 · cited 1×
“The comparable effect on vasodilatation in cultured vessels with the visible loss of the endothelium and in experimentally induced hypoxia is consistent with proposed endothelial cell dysfunction in FGR pregnancies (43).”
BackgroundEvidence for Progesterone Receptors in the Human Fetoplacental Vascular Tree1
Cudeville, C., Mondon, F., Robert, B., Rebourcet, R., Mignot, T.-M., Benassayag, C., & Ferré, F. (2000) · Biology of Reproduction · doi:10.1095/biolreprod62.3.759 · Cited by 20
Nacharaju, V. L., Divald, A., McCalla, C. O., Yang, L., & Muneyyirci‐Delale, O. (2004) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2004.00195.x · Cited by 10
Research works printed but not linked: 2
- Perinatal and Maternal Mortality Review Committee. Fifth Annual Report of the Perinatal and Maternal Mortality Review Committee: Reporting Mortality 2009. Health Quality and Safety Commission New Zealand, New Zealand; 2011.
- Chrousos GP. Adrenocorticoids and adrenocortical antagonists. In: Katzung BG, Masters SB, Trevor AJ, eds. Basic and Clinical Phar- macology. 10th ed. Columbus, OH: McGraw-Hill Medical; 2006: 635-652.
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Cortés, M. S., Carbajo, R. J., Crispi, F., Figueras, F., Pineda‐Lucena, A., & Gratacós, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080121 · Cited by 84
“transfer to the fetus has long been suggested as a potential pathogenic pathway of IUGR in humans [60,61].”
BackgroundPathogenesis of pregnancy complications in systemic lupus erythematosus
Østensen, M., & Clowse, M. E. B. (2013) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328363ebf7 · Cited by 72
“In a study [23] of placental resistance arteries, chronic treatment with glucocorticosteroids was found to potentiate vasoconstriction, thereby increasing the vascular resistance in the placenta.”
BackgroundSolano, M. E., Holmes, M. C., Mittelstadt, P. R., Chapman, K. E., & Tolosa, E. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0575-z · Cited by 67
“Similarly, chronic glucocorticoid over-exposure increases vascular resistance in the feto-placental circulation [97].”
BackgroundSafety issues of biologics in pregnant patients with rheumatic diseases
Østensen, M. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12456 · Cited by 53
Metadata
- Authors
- Nugent, J. L., Wareing, M., Palin, V., Sibley, C. P., Baker, P. N., Ray, D. W., Farrow, S. N., & Jones, R. L.
- Affiliations
- University of Manchester (GB)
- Maternal and Fetal Health Research Centre (J.L.N., M.W., V.P., C.P.S., R.L.J.)
- University of Auckland (NZ)
- Manchester Academic Health Science Centre (GB)
- Corresponding author
- Jones, R. L.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2013-01-07
- Volume
- 154
- Issue
- 2
- Pages
- 876-887
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2008362733
- Cited by
- 33
- References
- 50
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 2 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 4 · 2015: 2 · 2014: 3 · 2013: 4
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- GlaxoSmithKline
- Action Medical Research
- National Institute for Health and Care Research
- Manchester Biomedical Research Centre
- Medical Research Council
- Engineering and Physical Sciences Research Council (EP/I037253/1)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- fetal growth restriction, glucocorticoids, glucocorticoid receptor, 11β-hydroxysteroid dehydrogenase type 2, endothelial nitric oxide synthase, mifepristone, thromboxane receptor, bradykinin receptors, prokineticin 1, cyclooxygenase-2
- MeSH terms
- Arteries, Carbenoxolone, Chorion, Dexamethasone, Female, Fetal Growth Retardation, Glucocorticoids, Humans, Hydrocortisone, Placenta, Pregnancy, Vasoconstriction, Vasodilation, Mifepristone, 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid, Placental Circulation, 11-beta-Hydroxysteroid Dehydrogenases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.